2-{4-[7,12,17-triphenyl-22,24-dithia-21,23-diazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-2-yl]phenoxy}acetic acid

ID: ALA333072

Chembl Id: CHEMBL333072

PubChem CID: 11061577

Max Phase: Preclinical

Molecular Formula: C46H30N2O3S2

Molecular Weight: 722.89

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)COc1ccc(-c2c3nc(c(-c4ccccc4)c4ccc(s4)c(-c4ccccc4)c4nc(c(-c5ccccc5)c5ccc2s5)C=C4)C=C3)cc1

Standard InChI:  InChI=1S/C46H30N2O3S2/c49-42(50)28-51-33-18-16-32(17-19-33)46-37-23-22-36(48-37)45(31-14-8-3-9-15-31)39-25-24-38(52-39)43(29-10-4-1-5-11-29)34-20-21-35(47-34)44(30-12-6-2-7-13-30)40-26-27-41(46)53-40/h1-27H,28H2,(H,49,50)/b43-34-,43-38-,44-35-,44-40-,45-36-,45-39-,46-37-,46-41-

Standard InChI Key:  MFQXHQAPYZHTKZ-LBPAEDHKSA-N

Associated Targets(non-human)

R3230AC (34 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 722.89Molecular Weight (Monoisotopic): 722.1698AlogP: 12.25#Rotatable Bonds: 7
Polar Surface Area: 72.31Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.14CX Basic pKa: 5.47CX LogP: 10.82CX LogD: 9.31
Aromatic Rings: 7Heavy Atoms: 53QED Weighted: 0.18Np Likeness Score: -0.27

References

1. You Y, Gibson SL, Hilf R, Davies SR, Oseroff AR, Roy I, Ohulchanskyy TY, Bergey EJ, Detty MR..  (2003)  Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives.,  46  (17): [PMID:12904078] [10.1021/jm030136i]
2. Ngen EJ, Daniels TS, Murthy RS, Detty MR, You Y..  (2008)  Core-modified porphyrins. Part 6: Effects of lipophilicity and core structures on physicochemical and biological properties in vitro.,  16  (6): [PMID:18164203] [10.1016/j.bmc.2007.12.023]

Source